A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.
More top news
Two Danish radio hosts killed a rabbit with a bicycle pump live on air in a bid to highlight the "hypocrisy" of animal welfare campaigners.
The BBC has axed Never Mind the Buzzcocks after more than two decades.
Not a bad day at all - just a little patchy rain in the far north of Scotland.